Tender detail

Non-exclusive discount agreement for medicines containing abiraterone (excluding 500 mg)

Summary

The tender concerns the conclusion of non-exclusive pharmaceutical discount agreements for medicines containing abiraterone, excluding the 500 mg strength (ATC L02BX03). DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible. The agreements are planned to run from 1 October 2026 to 31 December 2027, with one possible 12-month extension, and will end automatically if an exclusive agreement enters into force. The reported submission deadline is 29 October 2028.

Reference number
571201-2026
Buyer
DAK-Gesundheit
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-10-29
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.